Literature DB >> 25761565

HMGB1 expression and muscle regeneration in idiopathic inflammatory myopathies and degenerative joint diseases.

Karolina Cseri1, János Vincze, Julianna Cseri, János Fodor, Zoltán Csernátony, László Csernoch, Katalin Dankó.   

Abstract

The High-Mobility Group Box 1 protein (HMGB1) is a known nuclear protein which may be released from the nucleus into the cytoplasm and the extracellular space. It is believed that the mobilized HMGB1 plays role in the autoimmune processes as an alarmin, stimulating the immune response. In addition, muscle regeneration and differentiation may also be altered in the inflammatory surroundings. Biopsy specimens derived from patients with idiopathic inflammatory myopathies (IIM) such as polymyositis or dermatomyositis were compared to muscle samples from patients undergoing surgical interventions for coxarthrosis. The biopsy and surgery specimens were used for Western blot analysis, for immunohistochemical detection of HMGB1 in histological preparations and for cell culturing to examine cell proliferation and differentiation. Our data show lower HMGB1 expression, impaired proliferation and slightly altered fusion capacity in the primary cell cultures started from IIM specimens than in cultures of coxarthrotic muscles. The ratio of regenerating muscle fibres with centralised nuclei (myotubes) is lower in the IIM samples than in the coxarthrotic ones but corticosteroid treatment shifts the ratio towards the coxarthrotic value. Our data suggest that the impaired regeneration capacity should also be considered to be behind the muscle weakness in IIM patients. The role of HMGB1 as a pathogenic signal requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25761565     DOI: 10.1007/s10974-015-9411-7

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  21 in total

Review 1.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 2.  HMG1 and 2: architectural DNA-binding proteins.

Authors:  J O Thomas
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

3.  Fluvastatin-induced alterations of skeletal muscle function in hypercholesterolaemic rats.

Authors:  Márta Füzi; Zoltán Palicz; János Vincze; Julianna Cseri; Zita Szombathy; Ilona Kovács; Anna Oláh; Péter Szentesi; Pál Kertai; György Paragh; László Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2011-11-09       Impact factor: 2.698

Review 4.  HMGB1 as a DNA-binding cytokine.

Authors:  Ulf Andersson; Helena Erlandsson-Harris; Huan Yang; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2002-12       Impact factor: 4.962

Review 5.  Idiopathic inflammatory myopathies.

Authors:  Melinda Vincze; Katalin Danko
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

6.  Expression of anti-Mullerian hormone receptor on the appendix testis in connection with urological disorders.

Authors:  Kornél Kistamás; Olga Ruzsnavszky; Andrea Telek; Lívia Kosztka; Ilona Kovács; Beatrix Dienes; László Csernoch; Tamás Józsa
Journal:  Asian J Androl       Date:  2013-01-07       Impact factor: 3.285

Review 7.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

8.  Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Joseph Bruton; Takashi Yamada; Therese Ostberg; David S Pisetsky; Helena Erlandsson Harris; Ulf Andersson; Ingrid E Lundberg; Håkan Westerblad
Journal:  FASEB J       Date:  2009-10-16       Impact factor: 5.191

9.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

Review 10.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

Authors:  David S Pisetsky; Helena Erlandsson-Harris; Ulf Andersson
Journal:  Arthritis Res Ther       Date:  2008-06-30       Impact factor: 5.156

View more
  6 in total

Review 1.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

2.  HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.

Authors:  Xiaoming Shu; Qinglin Peng; Xin Lu; Guochun Wang
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

3.  Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.

Authors:  Hongya Zhang; Fangyuan He; Ming Shi; Wenxiu Wang; Xiaojia Tian; Juan Kang; Wenjuan Han; Rui Wu; Linfu Zhou; Mengmeng Hu; Xiaobo Li; Fang Mi; Gang Zhao; Hongge Jia
Journal:  Front Neurol       Date:  2017-04-12       Impact factor: 4.003

4.  Localization and Expression of Nuclear Factor of Activated T-Cells 5 in Myoblasts Exposed to Pro-inflammatory Cytokines or Hyperosmolar Stress and in Biopsies from Myositis Patients.

Authors:  Sandrine Herbelet; Elly De Vlieghere; Amanda Gonçalves; Boel De Paepe; Karsten Schmidt; Eline Nys; Laurens Weynants; Joachim Weis; Gert Van Peer; Jo Vandesompele; Jens Schmidt; Olivier De Wever; Jan L De Bleecker
Journal:  Front Physiol       Date:  2018-02-21       Impact factor: 4.566

5.  Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies.

Authors:  Jessica Day; Sophia Otto; Kathy Cash; Preethi Eldi; Pravin Hissaria; Susanna Proudman; Vidya Limaye; John D Hayball
Journal:  Front Cell Dev Biol       Date:  2020-04-17

6.  Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.

Authors:  Xi Yin; Gen-Cheng Han; Xing-Wei Jiang; Qiang Shi; Chuan-Qiang Pu
Journal:  Chin Med J (Engl)       Date:  2016-05-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.